Tighter Testing New Normal For US OTC Sanitizer Firms Due To Contaminations During Pandemic
Executive Summary
With higher demand a norm, OTC sanitizer firms should do the same with scrutiny of their supplies of alcohol and other ingredients. “The market itself will always be much higher than a pre-COVID level as it’s a consumer product that is going to be used on a more regular basis,” says Ed Wyszumiala, head of US Pharmacopeia’s verification program.
You may also be interested in...
Plate Already Full Responding To Pandemic, US FDA Took On OTC Monograph Reform, ACNU Proposal
“The nonprescription drug space has been a bit challenging over the past two to three years as a result of the pandemic,” says CDER director Patrizia Cavazzoni.
US Still Rinsing Out OTC Sanitizer Warnings
Of GMP warnings for OTC hand sanitizers, 114 have been submitted by FDA since pandemic began, with first sent in late April 2020, and another 12 for false COVID-19 claims, with first sent on 1 April. One GMP warning for hand sanitizer product is listed in both 2018 and 2019.
COVID-19: US Regulators Continue Enforcement, FDA Commissioner Califf Has Positive Test Results
Califf experiencing mild symptoms after testing positive for COVID-19. FDA and FTC continue finding coronavirus-related fraud in consumer health products market.